NovoPedics
Biotechnology company developing implantable meniscus replacement and regeneration medical devices.
| Date | Investors | Amount | Round |
|---|---|---|---|
$500k | Seed | ||
| Total Funding | 000k | ||
Related Content
NovoPedics, Inc. is a medical device company focused on developing innovative solutions for severe meniscal knee injuries. The company's flagship product is a biodegradable polymer, fiber-reinforced scaffold designed for total meniscal replacement. This device mimics the native meniscus and can be attached to both soft tissue and bone, offering a comprehensive solution for patients with damaged meniscal tissue.
NovoPedics operates in the orthopedic medical device market, primarily serving patients who require knee surgery due to severe meniscal injuries. The business model revolves around the development, manufacturing, and distribution of its patented medical devices. Revenue is generated through the sale of these devices to hospitals, clinics, and orthopedic surgeons.
The company has received several accolades, including the Excellence in Research Award from the American Orthopaedic Society for Sports Medicine and a subaward through Rutgers U.S. Army Medical Research Acquisition Activity (USAMRAA).
Keywords: meniscal replacement, biodegradable scaffold, orthopedic device, knee surgery, medical innovation, fiber-reinforced, soft tissue attachment, bone attachment, mobility restoration, severe knee injuries.